ArticleScientific reports2026
Proteomic analysis revealed the potential usefulness of faecal extracellular vesicles in colorectal cancer diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer causes many deaths annually worldwide. We aimed to develop a new diagnostic method for colorectal cancer by analysing the protein profiles of extracellular vesicles in faeces. Enrichment analysis of proteomic data on extracellular vesicles highly purified from faeces by density gradient centrifugation revealed that proteins detected only in extracellular vesicles were significantly enriched in proteins derived from the colon. Notably, proteins detected only in faecal suspensions showed no enrichment in colon-derived proteins, suggesting that faecal extracellular vesicles can be used to detect changes in the protein profile that occur in the colon. In addition, we identified four candidate biomarkers among the proteins that were altered in the faecal extracellular vesicles of patients with colorectal cancer identified by proteomic analysis. By comparing different healthy control samples, olfactomedin-4 (OLFM4) and galectin-3-binding protein (LGALS3BP) in faecal extracellular vesicles were significantly increased in patients with colorectal cancer. This study shows that faecal extracellular vesicles are a promising biomarker resource for colorectal diseases, including colorectal cancers. Further analysis using faecal extracellular vesicles may lead to the development of novel diagnostic methods for colorectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.